Rapisone-D SR Capsule

Introduction

Rapisone-D SR is a prescription medication that contains two active ingredients: Eperisone and Diclofenac. It is used to provide relief from pain and inflammation associated with musculoskeletal conditions.

Uses

Rapisone-D SR is primarily prescribed for the treatment of musculoskeletal conditions such as muscle spasms, muscle stiffness, and joint pain caused by conditions like sprains, strains, or arthritis. It helps to reduce pain and inflammation, allowing patients to experience improved mobility and comfort.

Dosage and Administration

The dosage of Rapisone-D SR will vary depending on the severity of the condition and the individual patient’s response to the medication. Follow the instructions provided by your healthcare professional. Generally, the recommended dosage is one capsule taken orally, with or without food, one to three times a day. Do not exceed the prescribed dosage without consulting your doctor.

Mechanism of Action

Eperisone, one of the active ingredients in Rapisone-D SR, works by acting on the nervous system to relax and relieve muscle spasms. Diclofenac, the other active ingredient, belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing the production of certain chemicals in the body that cause pain and inflammation.

Side Effects

Common side effects may include nausea, stomach upset, dizziness, and headache. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as allergic reactions, difficulty breathing, or chest pain, seek medical attention immediately.

Drug Interactions

Rapisone-D SR may interact with certain medications, including blood thinners, diuretics, and certain antidepressants. Inform your healthcare professional about all the medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid any potential drug interactions. Your doctor will assess the risks and benefits of using Rapisone-D SR alongside other medications.

Precautions

There are certain precautions you should be aware of before using Rapisone-D SR. It is contraindicated in patients with a history of hypersensitivity or allergic reactions to any of the ingredients in the medication. Inform your doctor if you have any underlying medical conditions, such as heart, liver, or kidney problems, as they may affect the suitability of this medication for you. Additionally, avoid alcohol consumption while taking Rapisone-D SR, as it may increase the risk of stomach bleeding.

Storage

Patient Tips

• Take Rapisone-D SR exactly as prescribed by your healthcare professional.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
• Do not crush or chew the capsules; swallow them whole with a glass of water.
• If you experience any unusual symptoms or have concerns while taking Rapisone-D SR, consult your doctor for further guidance.
• Do not share this medication with others, as it is prescribed specifically for your condition.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Diclofenac: a non-steroidal anti-inflammatory drug (NSAID) for pain and swelling (NHS UK) [Accessed 0 Jun. 2024] (online) Available at:
• Diclofenac 2.32% gel (Health Professionals SmPC) Available at:
• Diclofenac (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• aleve (diclofenac) 1 % topical gel non-steroidal anti-inflammatory agents (nsaid) (OTC) [Accessed 20 Jun. 2024] (online) Available at:
• Diclofenac Topical (arthritis pain) [Accessed 5 Jun. 2024] (online) Available at:
• Hamed R, Mahmoud NN, Alnadi SH, Alkilani AZ, Hussein G. Diclofenac diethylamine nanosystems-loaded bigels for topical delivery: development, rheological characterization, and release studies. Drug Dev Ind Pharm. 2020 Oct;46(10):1705-1715. doi: 10.1080/03639045.2020.1820038. Epub 2020 Sep 18. [Accessed 23 Jun. 2024] Available at: